[Clinical assessment of myocardial protection utilizing crystalloid cardioplegia in neonates and infants--analysis with myocardial ultrastructures].
Sawa
Y
Y
Matsuda
H
H
Shimazaki
Y
Y
Ohtani
M
M
Kadoba
K
K
Takami
H
H
Hirose
H
H
Kawashima
Y
Y
Onishi
S
S
Nakada
T
T
D000367:Age Factors; D005947:Glucose / Q000008:administration & dosage / Q000009:adverse effects; D006324:Heart Arrest, Induced / Q000379:methods*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects; D008929:Mitochondria, Heart / Q000648:ultrastructure; D009206:Myocardium / Q000648:ultrastructure*; D011188:Potassium / Q000008:administration & dosage / Q000009:adverse effects
D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D005947:Glucose; D011188:Potassium